5 Things to Know About Cannabis Stocks in November 2022

Cannabis stocks are on the move once more, with U.S. decriminalization and legalization potentially happening across the country.

| More on:
A cannabis plant grows.

Source: Getty Images

There have been quite a few changes over the last few years in terms of cannabis stocks. And it goes far beyond merely legalization in Canada. In fact, there have been so many changes that in November alone, there could be quite a few things for interested investors to watch.

With that in mind, here are five things investors should know about cannabis stocks in November.

1. Decriminalization is on the table

No, decriminalization in the United States hasn’t happened yet. However, did make some changes in October that affected cannabis stocks significantly. For federal offences of “simple possession of marijuana,” the president announced a pardon. He then urged all governors to do the same.

Biden then put forward a proposal to change how marijuana is scheduled under the law. As of now, it’s currently a Schedule 1 classification, the same as heroin or LSD, and is, in fact, higher than substances like fentanyl. This as well could ease the transition to decriminalization.

2. Elections taking place

Investors should take a look at the elections taking place across the United States. There are several states that will be voting on marijuana legalization. While the substance is legal for medical use in 39 states, only 19 have legalized it recreationally.

This month, Arkansas, Maryland, Missouri, North Dakota, and South Dakota will vote on legalization. Should all of them vote in favour, that would bring in the total to 24 — almost half of the states in favour in the country. This again moves towards the growing movement of federal legalization.

3. Value already there

A recent report shows that cannabis is now the United States’s sixth most valuable crop. And again, I’ll stress that this crop is not legal in terms of recreational use across the country. The growing movement is there, but companies are also preparing by growing hemp and cannabidiol products.

The report by Leafly states that the product is now worth about US$5 billion per year. Adult-use cannabis farmers grew about 2,834 metric tons of cannabis during 2022 (which isn’t even over yet), all in 15 legal states.

4. Canopy Growth is growing

The news coming in from the White House in particular sent Canopy Growth (TSX:WEED) on the war path. The company stated for years that it would buy companies as soon as legalization happens in the United States.

Last month, Canopy Growth stock made good on that promise. It announced it would be acquiring Acreage, which will now make up about 75% of its U.S. revenue. This could seriously help the company meet its profit goals in the future should legalization occur.

5. Tilray comes in strong

Finally, early in November, Tilray (TSX:TLRY) also made a similar announcement that it acquired Montauk Brewing. However, unlike Canopy Growth stock, it’s looking to expand its alcohol division. What the company plans to do with Montauk, it didn’t say.

However, Tilray stock will have immense exposure to companies such as Walmart, Costco, and Target to name a few. Tilray has already stated it intends to use its other beverage brands to make products containing tetrahydrocannabinol (THC).

Bottom line

Cannabis stocks are on the move, with Canopy Growth stock and Tilray stock up 38% and 17%, respectively, in the last two weeks. So, that’s certainly reason enough to continue watching these two large cannabis stocks in the coming month.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe has positions in Canopy Growth Corp. The Motley Fool recommends Target and Walmart Inc. The Motley Fool has a disclosure policy.

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Could Aurora Cannabis Stock Finally Recover by Year-End?

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Are Pot Stocks About to Surge Again? 

With pot stocks making big moves of late, many investors are now asking whether the cannabis sector is worth investing…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »